Fujiwara T, Yokoyama H, Okitsu Y, Kamata M, Fukuhara N, Onishi Y, Fujimaki S, Takahashi S, Ishizawa K, Bresnick EH, Harigae H.
Gene expression profiling identifies HOXB4 as a direct downstream target of GATA-2 in human CD34+ hematopoietic cells.
PLoS One. 2012;7(9):e40959. doi: 10.1371/journal.pone.0040959.
Ichikawa S, Suzuki T, Kimura J, Harigae H.
Successful treatment of acute promyelocytic leukemia accompanied by serious subdural hematoma.
Intern Med. 2012;51(16):2209-12.
Ichikawa S, Hatta S, Saito Y, Kimura J, Onishi K, Matsuda M, Ichinohasama R, Harigae H.
CD20-positive and CD4/CD8-double-negative peripheral T-cell lymphoma of spleen complicated with severe disseminated intravascular coagulation and enteropathy.
J Clin Exp Hematop. 2012;52(2):133-6.
Inokura K, Onishi Y, Shimosegawa K, Okitsu Y, Katsuoka Y, Fujiwara T, Fukuhara N, Ishizawa K, Harigae H.
Philadelphia-negative acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic response after treatment with tyrosine kinase inhibitor.
Ann Hematol. 2012 Nov;91(11):1825-6. doi: 10.1007/s00277-012-1477-3.
Yamada-Fujiwara M, Miyamura K, Fujiwara T, Tohmiya Y, Endo K, Onishi Y, Ishizawa K, Kameoka J, Ito M, Harigae H.
Diagnosis of intestinal graft-versus-host disease and thrombotic microangiopathy after allogeneic stem cell transplantation.
Tohoku J Exp Med. 2012;227(1):31-7.
Kameoka J, Takahashi N, Noji H, Murai K, Tajima K, Kameoka Y, Sato S, Shichishima T, Ishida Y, Harigae H, Sawada K.
T-cell prolymphocytic leukemia in Japan: is it a variant?
Int J Hematol. 2012 Jun;95(6):660-7. doi: 10.1007/s12185-012-1077-y.
Shirai T, Fujii H, Ono M, Nakamura K, Watanabe R, Tajima Y, Takasawa N, Ishii T, Harigae H.
A novel autoantibody against fibronectin leucine-rich transmembrane protein 2 expressed on the endothelial cell surface identified by retroviral vector system in systemic lupus erythematosus.
Arthritis Res Ther. 2012 Jul 2;14(4):R157.
Suzuki M, Takahashi T, Katano I, Ito R, Ito M, Harigae H, Ishii N, Sugamura K.
Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/γcnull mouse.
Int Immunol. 2012 Apr;24(4):243-52. doi: 10.1093/intimm/dxs045.
Watanabe R, Ishii T, Nakamura K, Shirai T, Tajima Y, Fujii H, Harigae H.
Prevalence and time course of hepatitis B virus infection in patients with systemic lupus erythematosus under immunosuppressive therapy.
Mod Rheumatol. 2012 Nov 21. [Epub ahead of print]
Fujiwara T.
[Genome-wide analysis of GATA transcription factor in hematopoietic cells].
Rinsho Ketsueki. 2012 Mar;53(3):287-94. Review. Japanese.
Harigae H.
[109th Scientific Meeting of the Japanese Society of Internal medicine: symposium: 1. Recent treatments and progress in malignant tumors--chemotherapy and molecular targeting agents. Antibody therapy; 4) Progress and diversification in treatment for hematological malignancies].
Nihon Naika Gakkai Zasshi. 2012 Sep 10;101(9):2526-31. Japanese.
Aoyama S, Nakano H, Danbara M, Higashihara M, Harigae H, Takahashi S.
The differentiating and apoptotic effects of 2-aza-5'-deoxycytidine are dependent on the PU.1 expression level in PU.1-transgenic K562 cells.
Biochem Biophys Res Commun. 2012 Apr 20;420(4):775-81. doi: 10.1016/j.bbrc.2012.03.071.
Harigai M, Tanaka Y, Maisawa S; JA21963 Study Group.
Safety and efficacy of various dosages of ocrelizumab in Japanese patients with rheumatoid arthritis with an inadequate response to methotrexate therapy: a placebo-controlled double-blind parallel-group study.
J Rheumatol. 2012 Mar;39(3):486-95. doi: 10.3899/jrheum.110994.
Iseki Y, Nakahara M, Kubo M, Obata F, Harigae H, Takahashi S.
Correlation of PU.1 and signal regulatory protein α1 expression in PU.1 transgenic K562 cells.
Int J Mol Med. 2012 Feb;29(2):319-23. doi: 10.3892/ijmm.2011.827.
Kadirvel S, Furuyama K, Harigae H, Kaneko K, Tamai Y, Ishida Y, Shibahara S.
The carboxyl-terminal region of erythroid-specific 5-aminolevulinate synthase acts as an intrinsic modifier for its catalytic activity and protein stability.
Exp Hematol. 2012 Jun;40(6):477-86.e1. doi: 10.1016/j.exphem.2012.01.013.
Kameoka Y, Takahashi N, Ishizawa K, Kato Y, Ito J, Sasaki O, Murai K, Noji H, Hirokawa M, Tajima K, Shichishima T, Ishida Y, Harigae H, Sawada K.
Safety and feasibility of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous stem cell transplantation for malignant lymphoma.
Int J Hematol. 2012 Nov;96(5):624-30. doi: 10.1007/s12185-012-1186-7.
Okada Y, Shimane K, Kochi Y, Tahira T, Suzuki A, Higasa K, Takahashi A, Horita T, Atsumi T, Ishii T, Okamoto A, Fujio K, Hirakata M, Amano H, Kondo Y, Ito S, Takada K, Mimori A, Saito K, Kamachi M, Kawaguchi Y, Ikari K, Mohammed OW, Matsuda K, Terao C, Ohmura K, Myouzen K, Hosono N, Tsunoda T, Nishimoto N, Mimori T, Matsuda F, Tanaka Y, Sumida T, Yamanaka H, Takasaki Y, Koike T, Horiuchi T, Hayashi K, Kubo M, Kamatani N, Yamada R, Nakamura Y, Yamamoto K.
A genome-wide association study identified AFF1 as a susceptibility locus for systemic lupus eyrthematosus in Japanese.
PLoS Genet. 2012 Jan;8(1):e1002455. doi: 10.1371/journal.pgen.1002455.
Tagami K, Tanda S, Kato H, Tashiro A, Saji K, Komaru T, Tanida M, Nakura H, Ishizawa K.
Detection of asymptomatic cardiac metastasis and successful salvage chemotherapy comprising a prednisone, Etoposide, procarbazine, and cyclophosphamide regimen in an elderly Japanese patient suffering from a delayed recurrence of diffuse large B-cell lymphoma.
Case Rep Oncol. 2012 Jan;5(1):62-8. doi: 10.1159/000336447.
Takata K, Sato Y, Nakamura N, Tokunaka M, Miki Y, Yukie Kikuti Y, Igarashi K, Ito E, Harigae H, Kato S, Hayashi E, Oka T, Hoshii Y, Tari A, Okada H, Mohamad AA, Maeda Y, Tanimoto M, Kinoshita T, Yoshino T.
Duodenal follicular lymphoma lacks AID but expresses BACH2 and has memory B-cell characteristics.
Mod Pathol. 2013 Jan;26(1):22-31. doi: 10.1038/modpathol.2012.127.
Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, Ishizawa K, Maseki N, Itoh K, Usui N, Wasada I, Kinoshita T, Hotta T, Tsukasaki K, Oshimi K.
Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: An Updated Analysis of the Japan Clinical Oncology Group Study JCOG0211.
J Clin Oncol. 2012 Nov 10;30(32):4044-6. doi: 10.1200/JCO.2012.45.6541.